New Century Infusion Solutions Brings Increased Efficiency, Cost Savings to Oncology Managed Care.

BREA, Calif. -- New Century Infusion Solutions (NCIS) launched today as the first Integrated Single Specialty Provider (ISSP) focused on providing comprehensive management solutions to the oncology market. Designed to make oncology practices run more efficiently, NCIS is a cost-effective solution for payors and a valuable resource and advocate for oncologists and their very specific, complex needs.

NCIS bridges the gap between the disparate segments of oncology - the health plan, oncologists, and patients - to coordinate care, automate processes, optimize risk and reduce administrative burdens. By integrating and streamlining the management of oncology services, NCIS provides significant, often immediate cost savings for the payor and provider, and optimal quality of care for the patient.

"In the mature, yet highly fragmented oncology market, NCIS is the first and only comprehensive solutions provider that assumes full capitation and global risk management. As the industry's first Integrated Single Specialty Provider - or ISSP - NCIS manages all three complicated, yet integral pieces, for the health plan and individual oncologist - the medical, radiation/technical and drug components," said Joseph Perez, founder and chief executive officer of NCIS. "In a world where claims processing and referrals typically take weeks, now instant authorizations, referrals and timely payments to the providers are a reality."

With NCIS both payor and provider will realize immediate and long-term benefits, including:

* Instant savings to oncology risks and halted oncology drug inflationary trends in the long-term.

* A dedicated team of full-time oncology specialists to assist in the whole continuum of oncology services.

* Reduced administrative burdens.

* Integrated medication management.

* Timely referrals and payments for services.

A Closer Look: Cancer Statistics

About 1.4 million cancer cases are expected to diagnose in 2007. This year alone, more than half a million people will die from the disease. Cancer is the second-leading cause of death, exceeded only by heart disease in the U.S. The National Institutes of Health (NIH) estimates overall costs for cancer in 2006 at $206.3 billion: $78.2 for direct medical costs, $17.9 for indirect morbidity costs, and $110.2 billion for indirect mortality costs. These costs are partially due to the complexities of oncology and the various players that must be coordinated to make decisions about a patient's care.

"Managed care organizations (MCOs) must coordinate care for all disease states and therefore they are 'jack of all trades,' or generalists. However, in order to provide focused management of a complex disease such as oncology, objective specialists are necessary and that's where an ISSP like NCIS comes in," said Chris Nee, Pharm.D., chief operating officer of NCIS. "We are focused 100 percent on the cost-effective provision of quality oncology services for all stakeholders. NCIS strives to optimize efficiencies in the oncology sector that will allow physicians to spend less time on administrative tasks and minimizing risks so they can focus on what's really important: providing optimal, appropriate care to patients."

About New Century Infusion Solutions (NCIS)

Headquartered in Brea, Calif., NCIS is the first and only Single Specialty Provider (ISSP) that provides a participatory environment where providers and payors can realize cost-effective, appropriate care and achieve the best possible outcomes for patients. With its comprehensive best-in-breed solutions focused on professional, pharmacy and global risk management, NCIS "connects the dots" to manage all the intricacies of oncology and navigates the highly complex market with an inside out evidence-based approach. NCIS is designed to work with physicians, not against them. In a world where claims processing and referrals typically take weeks, under the NCIS model, now instant authorizations, referrals and timely payments are a reality. Always with the end-goal of optimal, appropriate patient care in mind, NCIS is the first, true bridge between the payor, the provider and the patient. For more information, visit www.newcenturyinfusionsolutions.com or call 1-888-999-7713.

To order a copy of Oncology Drug Management: A White Paper on Marketplace Challenges, Opportunities and Strategies, by Chris Nee, Pharm.D., M.B.A., and chief operating officer of New Century Infusion Solutions, visit www.aishealth.com/Products/odm.html.